News
4317 posts · page 36 of 180
Medtronic Ups 2027 Forecasts Amid Rising Heart Device Demand
Medtronic raises its fiscal 2027 forecasts, driven by strong heart device demand and strategic investments.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Amid IPO Success
Molbio Diagnostics posts Rs 52.7 crore profit in Q1, reversing last year's loss, driven by Truenat test-kit demand.
Medtronic Raises 2027 Forecasts Amid Rising Heart Device Demand
Medtronic boosts 2027 forecasts, driven by strong demand for heart devices and strategic investments.
Molbio Diagnostics Reports Rs 52.7 Cr Profit in First Quarter Post-IPO
Molbio Diagnostics, newly listed, reports Rs 52.7 crore Q1 profit, reversing last year's loss.
CDC Alerts Public to Rising Rabies Exposures Amid Summer Spike
The CDC warns of increased rabies exposures this summer, urging caution with wildlife.
Study Links Nighttime Light Exposure to Heart Damage
Exposure to light during sleep may alter heart structure, increasing cardiovascular risks.
Medtronic Ups 2027 Forecasts Amid Strong Heart Device Demand
Medtronic raises fiscal 2027 forecasts on robust heart device demand, investing in Pi-Cardia and Cornerstone Robotics.
Molbio Diagnostics Reports Rs 52.7 Cr Profit in First Post-IPO Quarter
Molbio Diagnostics swings to a Rs 52.7 crore profit in Q1, driven by robust Truenat test-kit sales.
AI Data Centers' Pollution Could Spike Healthcare Costs, Say Ex-EPA Officials
Gas-powered data centers might surge healthcare costs by $20 billion annually by 2028, warn former EPA officials.
Trump Offers $500 Rebates to Certain Obamacare Users Pre-Election
Trump's administration plans $500 rebates for higher-income ACA users in 30 states, weeks before the election.
Medtronic Raises 2027 Forecasts Amid Strong Heart Device Demand
Medtronic projects higher 2027 growth due to rising demand for cardiovascular devices and strategic investments in robotics.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 After IPO
Molbio Diagnostics sees a dramatic turnaround with a Rs 52.7 crore profit in Q1, driven by rising Truenat test-kit sales.
Medtronic Increases 2027 Forecasts Amid Rising Heart Device Demand
Medtronic raises fiscal 2027 revenue outlook due to strong demand for heart devices, investing in Pi-Cardia and Cornerstone Robotics.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Post-IPO
Molbio Diagnostics turns around with Rs 52.7 crore profit in Q1, fueled by Truenat test kit sales.
Poland's Physicians Face Challenges in Cannabis Pharmacovigilance
Polish doctors grapple with pharmacovigilance in medical cannabis use, highlighting knowledge gaps and reporting practices.
Complex Case of DRESS Syndrome in Patient with Osteomyelitis
A polymedicated osteomyelitis patient faces the diagnostic complexities of DRESS syndrome, complicating treatment plans.
Graph AI Secures $13.3M Series A to Enhance Drug Safety Automation
Graph AI advances drug safety automation with a $13.3M Series A funding round, aiming to revolutionize pharmacovigilance processes.
EMA's PRAC Meeting Reviews Key Safety Updates on Medicines
The EMA's PRAC convened to assess new safety data and review ongoing concerns about several medicines.
AstroKapoor Expands Global Reach with Online Astrology Services
AstroKapoor enhances its digital presence, offering expanded online astrology consultations for clients worldwide.
Medtronic Increases 2027 Forecasts Amid Rising Heart Device Demand
Medtronic raises its fiscal 2027 outlook, driven by strong demand for heart devices and strategic investments in Pi-Cardia and Cornerstone Robotics.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 After IPO
Molbio Diagnostics recorded a Rs 52.7 crore profit in Q1, rebounding from a prior loss, driven by strong Truenat test-kit sales.
Billy Joel Shares Health Update Following Brain Surgery
Billy Joel underwent surgery for hydrocephalus, a condition he was diagnosed with in 2025, citing concerns about his cognitive health.
Medtronic Raises Fiscal 2027 Forecasts Amid Heart Device Demand Surge
Medtronic boosts fiscal 2027 forecasts, driven by strong heart device demand and strategic investments.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Amid IPO Success
Molbio Diagnostics posts Rs 52.74 crore profit in Q1, rebounding from a Rs 23.94 crore loss last year.